The effect of specific IKKβ inhibitors on the cytosolic expression of IκB-α and the nuclear expression of p65 in dystrophic (MDX) muscle

American Journal of Translational Research

Volumn 7, Issue 4, 2015, Pages 670-682

  George Carlson, C George ^a   Dole, Elizabeth ^a   Stefanski, Casey ^a   Bayless, David ^a  

^a A T STILL UNIVERSITY   (United States)

Author keywords

BMS 345541; Duchenne muscular dystrophy; Inflammation; I b ; I B kinase; Mdx mouse; NF B signaling; P65; PHA 408

Indexed keywords

4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE INHIBITOR; INTERLEUKIN 1BETA; OCTAMER TRANSCRIPTION FACTOR 2; PHA 408; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFICACY; ENZYME ACTIVITY; IC50; IMMUNOFLUORESCENCE TEST; INFLAMMATION; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 84930392615     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bulfield G, Siller WG, Wight PA and Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 1984; 81: 1189-1192.
2. Kumar A and Boriek AM. Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. Faseb J 2003; 17: 386-396.
3. Monici MC, Aguennouz M, Mazzeo A, Messina C and Vita G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 2003; 60: 993-997.
4. Hayden MS and Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132: 344362.
5. Siebenlist U, Franzoso G and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405-455.
6. Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol 1997; 29: 867-870.
7. Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M and Kikugawa K. Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 2003; 22: 3356-3366.
8. Carlson CG, Samadi A and Siegel A. Chronic treatment with agents that stabilize cytosolic IkappaB-alpha enhances survival and improves resting membrane potential in MDX muscle fibers subjected to chronic passive stretch. Neurobiol Dis 2005; 20: 719-730.
9. Messina S, Bitto A, Aguennouz M, Minutoli L, Monici MC, Altavilla D, Squadrito F and Vita G. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 2006; 198: 234-241.
10. Siegel A., Bledsoe C, Lavin J, Gatti F, Berge J, Millman G, Turin E, Winders WT, Rutter J, Palmeiri B and Carlson CG. Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse. Neuromuscul Disord 2009; 19: 131-139.
11. Siegel A., Henley S, Zimmerman A, Miles M, Plummer R, Kurz J, Balch F, Rhodes JA, Shinn GL and Carlson CG. The influence of passive stretch and NF-kappaB inhibitors on the morphology of dystrophic muscle fibers. Anat Rec (Hoboken) 2011; 294: 132-144.
12. Miura T, Ouchida R, Yoshikawa N, Okamoto K, Makino Y, Nakamura T, Morimoto C, Makino I and Tanaka H. Functional modulation of the glucocorticoid receptor and suppression of NFkappaB-dependent transcription by ursodeoxycholic acid. J Biol Chem 2001; 276: 4737147378.
13. Graham KM, Singh R, Millman G, Malnassy G, Gatti F, Bruemmer K, Stefanski C, Curtis H, Sesti J and Carlson CG. Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway. J Neurol Sci 2010; 294: 43-50.
14. Acharyya S, Villalta SA, Bakkar N, Janssen PM, Carathers M, Li ZW, Beg AA, Ghosh S, Sahenk Z, Weinstein M, Gardner KL, Rafael-Fortney JA, Karin M, Tidball JG, Baldwin AS and Guttridge DC. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007; 117: 889-901.
15. Buetler TM, Renard M, Offord EA, Schneider H and Ruegg UT. Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species. Am J Clin Nutr 2002; 75: 749-753.
16. Whitehead NP, Pham C, Gervasio OL and Allen DG. N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice. J Physiol 2008; 586: 2003-2014.
17. Assereto S, Stringara S, Sotgia F, Bonuccelli G, Broccolini A, Pedemonte M, Traverso M, Biancheri R, Zara F, Bruno C, Lisanti MP and Minetti C. Pharmacological rescue of the dystrophin-glycoprotein complex in Duchenne and Becker skeletal muscle explants by proteasome inhibitor treatment. Am J Physiol Cell Physiol 2006; 290: C577-582.
18. Hnia K, Hugon G, Rivier F, Masmoudi A, Mercier J and Mornet D. Modulation of p38 mitogenactivated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice. Am J Pathol 2007; 170: 633-643.
19. Visconti R, Cerutti J, Battista S, Fedele M, Trapasso F, Zeki K, Miano MP, de Nigris F, Casalino L, Curcio F, Santoro M and Fusco A. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression. Oncogene 1997; 15: 1987-1994.
20. Balcerczak M, Balcerczak E, Pasz-Walczak G, Kordek R and Mirowski M. Expression of the p65 gene in patients with colorectal cancer: comparison with some histological typing, grading and clinical staging. Eur J Surg Oncol 2004; 30: 266-270.
21. Weichert W, Boehm M, Gekeler V, Bahra M, Langrehr J, Neuhaus P, Denkert C, Imre G, Weller C, Hofmann HP, Niesporek S, Jacob J, Dietel M, Scheidereit C and Kristiansen G. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis. Br J Cancer 2007; 97: 523-530.
22. Delhase M, Hayakawa M, Chen Y and Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 1999; 284: 309-313.
23. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R and Karin M. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999; 284: 316-320.
24. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R and Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 1999; 189: 18391845.
25. Burke JR, Pattoli MA, Gregor KR, Brassil PJ, MacMaster JF, McIntyre KW, Yang X, Iotzova VS, Clarke W, Strnad J, Qiu Y and Zusi FC. BMS 345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem 2003; 278: 1450-1456.
26. Mbalaviele G, Sommers CD, Bonar SL, Mathialagan S, Schindler JF, Guzova JA, Shaffer AF, Melton MA, Christine LJ, Tripp CS, Chiang PC, Thompson DC, Hu Y and Kishore N. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models. J Pharmacol Exp Ther 2009; 329: 14-25.
27. Singh R, Millman G, Turin E, Polisiakeiwicz L, Lee B, Gatti F, Berge J, Smith E, Rutter J, Sumski C, Winders WT, Samadi A and Carlson CG. Increases in nuclear p65 activation in dystrophic skeletal muscle are secondary to increases in the cellular expression of p65 and are not solely produced by increases in IkappaB-alpha kinase activity. J Neurol Sci 2009; 285: 159171.
28. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT and Kelly AM. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991; 352: 536-539.
29. Miles MT, Cottey E, Cottey A, Stefanski C and Carlson CG. Reduced resting potentials in dystrophic (mdx) muscle fibers are secondary to NF-kappaB-dependent negative modulation of ouabain sensitive Na+-K+ pump activity. J Neurol Sci 2011; 303: 53-60.
30. Carlson CG and Feng Y. Asynaptic expression of the adult nicotinic acetylcholine receptor in long-term cultures of mammalian myotubes. Brain Res Dev Brain Res 1993; 72: 245-252.
31. Carlson CG, Adkins SD, Blake MJ, Hasan AK and Loyland S. Differential influence of electrical blocking agents on embryonic acetylcholine receptor mRNA levels in long-term cultures of aneural mammalian myotubes. Synapse 1994; 18: 281-287.